COVID-19/Coronavirus
FDA Approves First Home Test to Detect Both Flu and COVID-19
Test will be sold without a prescription and can be used by anyone 14 years and older or by an adult or children ages 2 years and older A new at-home test will help people struggling with upper respiratory symptoms figure out whether they have COVID-19 or the flu. The U.S. Food and Drug Administration...
Many Face Months of Lingering Symptoms After COVID Hospital Discharge
Key Takeaways Yet another study confirms what millions who have had COVID already know: Symptoms linked to the infection can linger for months. More than 7 in 10 patients reported coughing, heartbeat irregularities and breathlessness six months later, while half suffered from fatigue and physical limitations. Not only that, more than half also said they had...
Fluvoxamine Does Not Improve Time to Sustained Recovery in Mild COVID-19
No difference seen for fluvoxamine, placebo in composite outcome of hospitalization, urgent care visit, emergency department visit, death. For patients with mild-to-moderate COVID-19, treatment with fluvoxamine does not improve time to sustained recovery versus placebo, according to a study published online on Jan. 12 in the Journal of the American Medical Association. Matthew W. McCarthy,...
The Need for Vaccines for COVID-19 Variants
Several COVID-19 vaccines have been developed, but additional effective vaccines are still needed to meet the global demand. A study showed that the fast appearance and spread of SARS-CoV2 variants of concern (VOCs), which have the potential to evade neutralizing antibodies or cell-mediated immunity, can jeopardize vaccine effectiveness (VE). Several pneumonia cases with unclear etiologies...
Low-Certainty Evidence Behind Ivermectin for COVID-19
The antiparasitic drug ivermectin inhibits in-vitro replication of viruses. However, there has been conflicting information about the effectiveness of ivermectin for treating COVID-19 and preventing SARS-CoV-2 infection. COVID-19 infections require affordable, widely accessible, and efficient treatments. Ivermectin’s effectiveness in treating COVID-19 infections has yielded conflicting results in clinical trials. The drug is believed to work...
COVID-19 Vaccination in Patients with NMOSD and Multiple Sclerosis
Patients with multiple sclerosis or NMOSD may have more complications with the COVID-19 vaccination when compared to the general population. Although vaccination against COVID-19 provides excellent protection against severe infection, this effect may be mitigated to some degree among those taking immunomodulatory medications, including those with multiple sclerosis or neuromyelitis optica spectrum disorders (NMOSD). This...
CDC Panel: Add COVID-19 Shot to Routine Vaccine Schedule
In a unanimous vote on Thursday, a panel of U.S. vaccine experts recommended that COVID-19 shots be added to the list of recommended vaccinations for children and adults. Now it is up to the U.S. Centers for Disease Control and Prevention to decide whether to follow the advice of its Advisory Committee on Immunization Practices....
Vitiligo Patients and COVID-19
Research suggests that vitiligo patients may experience a decreased risk of hospitalization and death from COVID-19. The potentially protective effects against infection with SARS-CoV-2 may be explained by different mechanisms. Vitiligo has been linked to a lower quality of life and a variety of autoimmune disorders, which may increase the likelihood of poor COVID-19 outcomes....
Significance of Increased Mental Health Symptoms During the COVID-19 Pandemic
Although mental health symptoms increased during the COVID-19 pandemic, findings show that this increase was short-lived. Changes to mental health were widely reported throughout the COVID-19 pandemic, throughout various locations, socioeconomic levels, and other demographic factors. The purpose of this study, published in the Journal of Affective Disorders, was to analyze these changes throughout 2020,...
More Medical News
